Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases.
Franzese C, Comito T, Tripoli A, Franceschini D, Clerici E, Navarria P, Badalamenti M, D'agostino G, Loi M, Mancosu P, Reggiori G, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: loi m. Clin Exp Metastasis. 2020 Oct;37(5):565-573. doi: 10.1007/s10585-020-10047-x. Epub 2020 Jun 15. Clin Exp Metastasis. 2020. PMID: 32556682 Clinical Trial.
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
Meattini I, Livi L, Saieva C, Franceschini D, Scotti V, Mangoni M, Loi M, Di Brina L, Zei G, Bonomo P, Greto D, Gelain E, Nori J, Sanchez LJ, Orzalesi L, Bianchi S, Biti G. Meattini I, et al. Among authors: loi m. Clin Breast Cancer. 2013 Aug;13(4):247-53. doi: 10.1016/j.clbc.2013.02.005. Epub 2013 May 15. Clin Breast Cancer. 2013. PMID: 23684167
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
Franzese C, Comito T, Franceschini D, Loi M, Clerici E, Navarria P, De Rose F, Di Brina L, Mancosu P, Reggiori G, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: loi m. J Cancer Res Clin Oncol. 2020 May;146(5):1227-1234. doi: 10.1007/s00432-020-03148-3. Epub 2020 Feb 13. J Cancer Res Clin Oncol. 2020. PMID: 32056005
Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C, Bonu ML, Comito T, Clerici E, Loi M, Navarria P, Franceschini D, Pressiani T, Rimassa L, Scorsetti M. Franzese C, et al. Among authors: loi m. J Cancer Res Clin Oncol. 2020 Sep;146(9):2289-2297. doi: 10.1007/s00432-020-03285-9. Epub 2020 Jun 10. J Cancer Res Clin Oncol. 2020. PMID: 32524292
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification?
Franzese C, Badalamenti M, Comito T, Franceschini D, Clerici E, Navarria P, Loi M, D'agostino G, Baldaccini D, Chiola I, Reggiori G, Mancosu P, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: loi m. Radiother Oncol. 2020 Sep;150:184-190. doi: 10.1016/j.radonc.2020.06.029. Epub 2020 Jun 25. Radiother Oncol. 2020. PMID: 32593644
427 results